Thyrocare Technologies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Rahul Guha
Chief executive officer
₹31.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.4yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04CEO
Rahul Guha (45 yo)
2yrs
Tenure
₹31,801,079
Compensation
Mr. Rahul Franklin Guha is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 2022 and also serves as its Chairman since April 07, 2023. He joined the Th...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Chairman | 2yrs | ₹31.80m | 0.099% ₹ 33.8m | |
| Chief Operating Officer | no data | ₹9.89m | 0.0030% ₹ 1.0m | |
| Company Secretary & Compliance Officer | 9.7yrs | ₹3.09m | 0.040% ₹ 13.6m | |
| Vice President | no data | ₹5.33m | 0.0020% ₹ 681.8k | |
| Chief Financial Officer | less than a year | no data | 0.00094% ₹ 320.5k | |
| Head of Strategy & Investor Relations | no data | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
1.4yrs
Average Tenure
45yo
Average Age
Experienced Management: THYROCARE's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Chairman | 2yrs | ₹31.80m | 0.099% ₹ 33.8m | |
| Independent Non-Executive Director | 9.8yrs | ₹160.00k | no data | |
| Independent Non-Executive Director | 9.7yrs | ₹50.00k | no data | |
| Non-Executive Independent Director | 6.8yrs | ₹70.00k | no data | |
| Non-Executive & Non-Independent Director | 2.7yrs | no data | no data | |
| Non Executive Director | 2.7yrs | no data | no data | |
| Non Executive Director | 2.6yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Non-Executive Independent Director | less than a year | no data | no data |
2.7yrs
Average Tenure
35yo
Average Age
Experienced Board: THYROCARE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.